Current Partners
Partnering Opportunities
BrainCells is in active discussions to partner our mGluR2/3 antagonism program with a leading company in the CNS field. We seek a partner with extensive development and commercialization capabilities on a worldwide basis.
Outlicensing
BrainCells is also seeking to outlicense our non-strategic assets.
Direct partnership inquiries to:
Robert F. Williamson, Acting CEO: rwilliamson@braincellsinc.com
Susan E. Dube’, Acting CBO: sdube@braincellsinc.com